Modern medicine, often a near miracle, creates more challenges to solve. For instance, the adoption worldwide of antiretroviral therapies to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives. However, with this extension of life comes increased risk for cancer. Thankfully, for a quarter of a century now, the AIDS Malignancy Consortium (AMC) spearheads national and international initiative to prevent and treat HIV-related cancers. Now the National Cancer Institute (NCI) has granted $111 million over five years to Montefiore Health System and Albert Einstein College of Medicine to lead this research consortium and intensify the battle against HIV-related cancer.
The “AIDS Malignancy Consortium” grant is funded by the National Cancer institute, part of the National Institutes of Health (2UM1CA121947). New York City-based Montefiore Health System and Albert Einstein College of Medicine came together to issue a press release and inform the world about the grant to take this challenge on.
Approximately 38 million people are infected with HIV, including 1.2 million in the U.S. ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).